To the Editor.— Vincristine sulfate, a commonly used chemotherapeutic drug, is often associated with severe tissue reactions when extravasated subcutaneously. I would like to report my experience with two cases that seemed to be treated effectively with hydrocortisone. Report of Cases.— Case1.—A 63-year-old woman with a history of multiple myeloma was given vincristine sulfate, 2 mg intravenously (IV), as part of her chemotherapy. Approximately 1.5 mL of vincristine sulfate was extravasated subcutaneously in the volar aspect of the left arm. Hydrocortisone, 100 mg, was infiltrated subcutaneously in the region of the extravasation. The patient was seen one week later, and although there was some initial pain and some edema, this had subsided completely, and the area was healing satisfactorily. On further follow-up, there were no sequelae noted. Case2.—A 73-year-old woman with a history of breast carcinoma received vincristine sulfate, 1 mg IV. During administration, approximately 3 mL of